Author:
Berthiaume J. M.,Wallace K. B.
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Cell Biology,Toxicology
Reference70 articles.
1. al-Shabanah OA, Badary OA, Nagi MN, et al. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res. 1998;17:193–8.
2. Anderson AB, Arriaga EA. Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM/C2 cell lines after treatment with doxorubicin. J Chromatogr B Anal Technol Biomed Life Sci. 2004;808:295–302.
3. Arcamone F, Franceschi G, Penco S, Selva A. Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Lett. 1969;13:1007–10.
4. Ardail D, Privat JP, Egret-Charlier M, et al. Mitochondrial contact sites. Lipid composition and dynamics. J Biol Chem. 1990;265:18797–802.
5. Arola OJ, Saraste A, Pulkki K, et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000;60:1789–92.
Cited by
345 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献